Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-10-29

Clinical Trial Update: Post Operative Pain Control for Distal Radius Surgery: Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours ? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Exparel for postoperative pain after distal radius surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Post Operative Pain | Phase 4 | Status: WITHDRAWN